Regeneron Pharmaceuticals, Inc. $(REGN)$ is currently at $503.78, down $101.61 or 16.78%
--Would be lowest close since June 1, 2021, when it closed at $503.23
--On pace for largest percent decrease since April 29, 2011, when it fell 21%
--Currently down five of the past seven days
--Down 15.86% month-to-date; on pace for worst month since Oct. 2024, when it fell 20.27%
--Down 29.28% year-to-date
--Down 58.08% from its all-time closing high of $1201.76 on Aug. 27, 2024
--Down 48.60% from 52 weeks ago (May 31, 2024), when it closed at $980.16
--Down 58.08% from its 52-week closing high of $1201.76 on Aug. 27, 2024
--Would be a new 52-week closing low
--Traded as low as $493.15; lowest intraday level since May 27, 2021, when it hit $492.13
--Down 18.54% at today's intraday low; largest intraday percent decrease since April 29, 2011, when it fell as much as 21.45%
--Worst performer in the S&P 500 today
--Worst performer in the Nasdaq 100 today
All data as of 10:20:21 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 30, 2025 10:23 ET (14:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。